Patent · US Active

Platelet-derived growth factor B mutant, preparation method therefor and use thereof

US10450358B2 · kind B2 · utility

0Cited by

7References

11Claims

0Family size

Assignee

Institute of Biotechnology, Academy of Military Medical Sciences, China · CN

Inventors

Wei-Ming Chen · Hsinchu, TW
Xiaopeng Zhang · Palo Alto, US
Changming Yu · 红钢城街道, CN
Ling Fu · Beijing, CN
Mengmeng Dai · Beijing, CN
Jun Zhang · Xiamen, CN
Junjie Xu · Hangzhou City, CN
Lihua Hou · Beijing, CN
Jianmin Li · Beijing, CN

Key dates

Filing date	Jul 16, 2015
Grant date	Oct 22, 2019
Priority date	—
Expiry date	Jul 16, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

Provided are a platelet-derived growth factor B derivative, the encoding nucleic acid molecule thereof, and a vector and host cell having the nucleic acid molecule. Also provided are a preparation method for the mutant, and the use of the mutant in preparing medications for promoting cell division, cell proliferation, wound healing, skin regeneration, bone and tooth defect regeneration, and joint repair.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.